A comparison between spinal cord infarction and neuromyelitis optica spectrum disorders: Clinical and MRI studies

被引:0
|
作者
Jung Lung Hsu
Mei-Yun Cheng
Ming-Feng Liao
Hui-Ching Hsu
Yi-Ching Weng
Kuo-Hsuan Chang
Hong-Shiu Chang
Hung-Chou Kuo
Chin-Chang Huang
Rong-Kuo Lyu
Kun-Ju Lin
Long-Sun Ro
机构
[1] Chang-Gung University,Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center and College of Medicine
[2] Graduate Institute of Mind,Institute of Molecular Medicine
[3] Brain,Department of Traditional Chinese Medicine, Division of Chinese Acupuncture and Traumatology, Chang Gung Memorial Hospital
[4] and Consciousness,Department of Nuclear Medicine and Center for Advanced Molecular Imaging and Translation
[5] Taipei Medical University,Department of Medical Imaging and Radiological Sciences and Healthy Aging Research Center
[6] Taipei and Brain and Consciousness Research Center,undefined
[7] TMU Shuang Ho Hospital,undefined
[8] National Tsing Hua University,undefined
[9] Linkou Medical Center and Chang Gung University College of Medicine,undefined
[10] Linkou Chang Gung Memorial Hospital,undefined
[11] Chang Gung University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This study aims to investigate the clinical features and magnetic resonance imaging (MRI) findings in patients with spinal cord infarction (SCI) and neuromyelitis optica spectrum disorders (NMOSDs). Over a period of 16 years, we retrospectively analyzed 39 patients with SCI and 21 patients with NMOSD. The demographic features and clinical presentations of both diseases were carefully documented. Etiology-specific MRI features, such as the length and distribution of the lesions, the owl’s eyes sign and bright spotty lesions, were recorded and analyzed regarding their association with the clinical signs/symptoms. Patients with SCI were older than patients with NMOSD and had sudden onset of clinical symptoms with focal pain adjacent to the lesions. Concomitant spinal cord and vertebral body infarctions were frequently associated with aortic pathology (p = 0.04). In addition, artery dissection was highly associated with combined ASA and unilateral PSA infarctions and long segments of SCI (all p < 0.05). In contrast, patients with NMOSD had a relatively younger age of onset, female predominance and subacute progression of limbs weakness. As observed by MRI, the length and location of the lesions demonstrated significant differences between the two diseases (P < 0.01). The owl’s eyes sign showed more frequently in patients with SCI than NMOSD (p < 0.01). The predicted prognoses in SCI and NMOSD were significantly associated with initial motor function (muscle power), after adjustments for age and gender (p < 0.01 and p = 0.02, respectively). Along with patient demographic characteristics, lesion features on MRI can help clinicians differentiate acute noncompressive myelopathy due to SCI from that due to NMOSD, which may lead to immediate initiation of adequate therapeutic measures.
引用
收藏
相关论文
共 50 条
  • [41] No differences in spinal cord DTI abnormalities between neuromyelitis optica spectrum disorder and multiple sclerosis
    Cortese, R.
    Magnollay, L.
    De Angelis, F.
    Prados, F.
    Grussu, F.
    Tur, C.
    Yiannakas, M.
    Simone, I. L.
    Altmann, D. R.
    Miller, D.
    Ourselin, S.
    Wheeler-Kingshott, C. M. Gandini
    Barkhof, F.
    Ciccarelli, O.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 525 - 526
  • [42] Prognostic factors in a cohort of neuromyelitis optica and neuromyelitis optica spectrum disorders
    Orviz-Garcia, A.
    Gonzalez-Suarez, I.
    Matias-Guiu, J.
    Oreja-Guevara, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 375 - 375
  • [43] Spinal dural fistula mimicking neuromyelitis optica spectrum disorders (NMODS)
    Paiva, J.
    Paula, L.
    Almeida, M.
    Silva, A.
    Portilho, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [44] Neuromyelitis optica spectrum disorders Comparison according to the phenotype and serostatus
    Sepulveda, Maria
    Armangue, Thas
    Sola-Valls, Nuria
    Arrambide, Georgina
    Meca-Lallana, Jose E.
    Oreja-Guevara, Celia
    Mendibe, Mar
    Alvarez de Arcaya, Amaya
    Aladro, Yolanda
    Casanova, Bonaventura
    Olascoaga, Javier
    Jimenez-Huete, Adolfo
    Fernandez-Fournier, Mireya
    Ramio-Torrenta, Lluis
    Cobo-Calvo, Alvaro
    Vinals, Montserrat
    de Andres, Clara
    Meca-Lallana, Virginia
    Cervello, Angeles
    Calles, Carmen
    Baron Rubio, Manuel
    Ramo-Tello, Cristina
    Caminero, Ana
    Munteis, Elvira
    Antiguedad, Alfredo R.
    Blanco, Yolanda
    Villoslada, Pablo
    Montalban, Xavier
    Graus, Francesc
    Saiz, Albert
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (03):
  • [45] Spinal cord atrophy in neuromyelitis optica is spatially associated to spinal cord lesions and clinical disability
    Cacciaguerra, L.
    Valsasina, P.
    Mesaros, S.
    Radaelli, M.
    Drulovic, J.
    Filippi, M.
    Rocca, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 452 - 453
  • [46] Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction
    Kister, I.
    Johnson, E.
    Raz, E.
    Babb, J.
    Loh, J.
    Shepherd, T. M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 62 - 67
  • [47] Clinical and prognosis profile of paraneoplastic neuromyelitis optica spectrum disorders
    Sepulveda, M.
    Sola-Valls, N.
    Escudero, D.
    Llufriu, S.
    Blanco, Y.
    Saiz, A.
    Graus, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 90 - 90
  • [48] Clinical characteristics of neuromyelitis optica spectrum disorders in a spanish population
    Hiraldo, J. D. G.
    Lopez Ruiz, R.
    Sanchez Fernandez, F.
    Dotor Garcia-Soto, J.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Navarro Mascarell, G.
    Eichau Madueno, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 452 - 452
  • [49] Neuromyelitis optica spectrum disorders: an update
    Palace, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 23 - 23
  • [50] Neuromyelitis Optica Spectrum Disorders (NMOSD)
    Christopher C. Glisson
    Current Treatment Options in Neurology, 2022, 24 : 241 - 251